Posted inIndustrial News
CSPC Pharmaceutical & AstraZeneca Announce Biologics Manufacturing JV in China.
CSPC Pharmaceutical and AstraZeneca have entered into a 51:49 joint venture agreement to develop a next-generation biologics manufacturing facility in Shijiazhuang, China. The partnership is designed to combine complementary strengths: 🔹 CSPC…